Table 1.
Demographics of healthy subjects valid for pharmacokinetic analyses in the ketoconazole, clarithromycin, and midazolam studies
| Characteristic | Ketoconazole study (n = 16) |
Clarithromycin study (n = 15) |
Midazolam study (n = 22) |
|---|---|---|---|
| Male, no. (%) | 16 (100) | 15 (100) | 22 (100) |
| Age, mean (range), years | 42.3 (27.0–54.0) | 34.5 (26.0–45.0) | 36.5 (26.0–45.0) |
| Height, mean (SD), cm | 179.8 (7.9) | 181.3 (7.5) | 181.3 (7.1) |
| Weight, mean (SD), kg | 83.4 (10.8) | 80.6 (10.7) | 80.8 (9.6) |
| BMI, mean (SD) | 25.8 (2.5) | 24.5 (2.5) | 24.6 (2.4) |
Note
BMI: body mass index; SD: standard deviation.